Integrity Applications Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IGAP Over the counter 2835 http://www.integrity-app.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Integrity Applications Inc

Integrity Applications Appoints Paul V. Goode, PhD, to Board of Directors - Dec 17th, 2020 2:15 pm
Integrity Applications Names Shalom Shushan as Chief Technology Officer - Nov 5th, 2020 2:18 pm
Integrity Applications Provides Commercial Update - Sep 14th, 2020 1:00 pm
Integrity Applications Expands and Strengthens Team with Appointment of Erez Ben-Zvi as Vice President of Product - Jul 13th, 2020 1:00 pm
Integrity Applications Announces the Appointment of Yair Briman as Senior Executive Advisor - Apr 22nd, 2020 1:00 pm
Integrity Applications Issues Shareholder Update Letter - Apr 14th, 2020 8:45 pm
Integrity Applications Announces Closing of $15.0 Million Private Placement - Feb 24th, 2020 2:00 pm
Integrity Applications Receives CE Mark Approval for Self-Calibration Version of its GlucoTrack® Non-Invasive Glucose Monitoring Device - Jan 21st, 2020 2:00 pm